Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in palatopalatyngoplasty
NCT03612440Unknown
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Aug 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in obstructive sleep apnea syndrome (OSAS) (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Oxygenation Index and Respiratory Index. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT03612440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03612440.